产品名称 | NebuSelect™ Recombinant Human IL-8/CXCL8, His-tag |
---|---|
目录号 | NBL-242461 |
别名 | IL-8/CXCL8; Interleukin-8; IL-8; GCP-1; MDNCF; MONAP; NAP-1; GCP/IL-8 protein IV; IL8/NAP1 form I; CXCL8; LECT; LUCT; LYNAP; NAF |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P10145-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242461-100ug | 100ug | Inquire | Inquire | |
NBL-242461-1mg | 1mg | Inquire | Inquire | |
NBL-242461-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IL-8/CXCL8, His-tag
Catalog#:
NBL-242461
Description:
NebuSelect™ Recombinant Human IL-8/CXCL8, His-tag(Cat#NBL-242461) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser28-Ser99.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 9.5 kDa. Due to glycosylation, the protein migrates to 11-13 kDa based on Bis-Tris PAGE result.
Target Name:
IL-8/CXCL8; Interleukin-8; IL-8; GCP-1; MDNCF; MONAP; NAP-1; GCP/IL-8 protein IV; IL8/NAP1 form I; CXCL8; LECT; LUCT; LYNAP; NAF
Target Information:
Interleukin-8 (IL-8) has been revealed as a critical regulator of CNS function and development with participation in many CNS disorders including gliomas.Several promising approaches that target directly or indirectly IL-8 effects in gliomas are currently in progress while more-in-depth studies are needed to validate its biomarker role and elucidate the underlying molecular mechanisms.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.